Login / Signup

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study.

Amanda RaoPhillippa EbeltAlistair MallardDavid Briskey
Published in: Sleep science and practice (2021)
Australian New Zealand Clinical Trials Registry ACTRN12618001339246. Registered 9th August 2018.
Keyphrases
  • clinical trial
  • placebo controlled
  • double blind
  • phase ii
  • study protocol
  • open label
  • phase iii
  • physical activity
  • randomized controlled trial
  • sleep quality
  • depressive symptoms
  • phase ii study